SORRENTO THERAPEUTICS, INC. Common Stock (par value $0.0001 per share) At Market Issuance Sales AgreementSorrento Therapeutics, Inc. • November 4th, 2014 • Services-commercial physical & biological research • New York
Company FiledNovember 4th, 2014 Industry JurisdictionSorrento Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows: